AI ee Kediska Tijaabada Caafimaadka

Jawaabaha iyo sharraxaadaha waxay soo baxayaan markaad qaadanayso kediska.

1. Waa kuwee dhibatada mudada dheer soo jirtay ee tijaabooyinka kiliinikada ee AI ay sida tooska ah u beegsanayso?
   • Shaqaalaysiinta bukaanka oo gaabis ah oo adag
   • Midabka baakadaha daawada
   • Cutubyada kafateeriyada isbitaalka
   • Helitaanka baarkinka ee goobaha tijaabada
2. How can natural-language processing help screen patients for clinical trials?
   • Adigoo ka boodaya dib u eegista badbaadada
   • Extract clinical information from electronic health records and compare it with trial eligibility criteria
   • Iyadoo la siinayo bukaannada wax ka badan kuwa tartamaya
   • Iyadoo lagu soo koobay tijaabada hal maalin
3. What is an external control arm in a clinical trial?
   • Xubin robotik ah
   • Unug dawooyinka kombuyuutar laga soo saaray
   • A comparison group drawn from data outside the trial, such as historical or concurrent external data
   • A server xogta kaabta
4. What can propensity-score matching do when constructing an external-control comparison?
   • Kala soocida alifbeetada
   • Jiilka tirada random kali ah
   • Higgaad hubinta
   • Balance measured baseline covariates related to treatment assignment
5. Maxay tahay sababta ka tegista saadaalinta ah iyo moodooyinka waxqabadka goobta ay muhiim ugu yihiin kafaala-qaadayaasha tijaabada?
   • Waxay u ogolaadeen kafaala qaadayaasha inay soo farageliyaan ka hor inta aanay maxkamadu dhicin
   • Waxay naqshadeeyaan dhismaha dhismaha
   • Waxay qoraan hal-ku-dhegyada suuq-geynta
   • Waxay doortaan dirayska shaqaalaha
6. What does FDA’s January 2025 draft AI guidance address for drugs and biologics?
   • Si loo yareeyo dhammaan cilmi-baarista si joogto ah
   • AI used to generate information supporting regulatory decisions about safety, effectiveness, or quality
   • Sababtoo ah AI waa sharci darro daawada
   • Si loo yareeyo tirada dhakhaatiirta
7. What can a Bayesian adaptive clinical-trial design change as evidence accumulates?
   • The original trial question after results are known
   • The identity of past participants
   • Trial elements such as dosing or allocation to study arms under prespecified rules
   • The inclusion criteria without documentation
8. Which pharmacovigilance tasks does FDA identify as possible uses for emerging AI?
   • Only advertising click-through rates
   • Satellite images of clinical sites
   • Unrelated social-media sentiment about packaging
   • Adverse-event intake, data entry, processing, and safety-signal detection or evaluation